Showing 2971-2980 of 3762 results for "".
Diagnosing Zika; Aspire Higher Scholarship Program; Call for Abstracts
https://practicaldermatology.com/youngmd-connect/resident-resource-center/diagnosing-zika-aspire-higher-scholarship-program-call-for-abstracts/20517/PRP for Scarring Hair Disorders: Thoughts on Patient Care
https://practicaldermatology.com/topics/hair-nails/prp-for-scarring-hair-disorders-thoughts-on-patient-care/23231/Pearls for supporting patients and implementing PRP in practice.What's New in Topical Acne Therapy
https://practicaldermatology.com/topics/practice-management/whats-new-in-topical-acne-therapy/21105/From new approvals to a growing pipeline, the outlook is bright for the continued refinement of topical acne therapy.Is Bone Mineral Density Testing Indicated with Long-Term IM Triamcinolone Acetonide Therapy?
https://practicaldermatology.com/topics/general-topics/PD1208_05-php/22603/Prospective data are lacking, but early findings suggest little if any risk of density-loss among patients on long-term therapy.Update: Biomarkers for Guiding Treatment in Early Stage Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-biomarkers-for-guiding-treatment-in-early-stage-melanoma/23260/A look at current tools for risk stratification of melanoma, controversy surrounding SLNB for staging, and novel adjuvant immunotherapies for early stage disease.Bimekizumab-bkzx Journal Scan: 4 Clinical Trials
https://practicaldermatology.com/topics/digital-supplement/bimekizumab-bkzx-journal-scan-4-clinical-trials/24128/Speed, depth, and durability from the first dual IL-17A/F inhibitor for the treatment of moderate to severe plaque psoriasis.Rosacea Update: A Closer Look at Zilxi
https://practicaldermatology.com/columns/clinical-focus-1/rosacea-update-a-closer-look-at-zilxi/23339/Inside the approval of Zilxi for moderate-to-severe facial papulopustular rosacea.Understanding a New Method of Assessing Psoriasis Severity
https://practicaldermatology.com/columns/clinical-focus-1/understanding-a-new-method-of-assessing-psoriasis-severity/23157/New method aims to improve access to systemic psoriasis therapy.Upadacitinib and Cardiovascular Events in AD
https://practicaldermatology.com/issues/october-2025/upadacitinib-and-cardiovascular-events-in-ad/39755/A recent review examined whether upadacitinib, a selective Janus kinase 1 (JAK1) inhibitor approved for atopic dermatitis (AD) and other chronic inflammatory diseases, may—despite a boxed warning to the contrary—confer cardioprotective and thromboprotective effects.The Evidence for Slow- and Fast-growing Melanomas
https://practicaldermatology.com/topics/skin-cancer-photoprotection/1109_06-php/22058/Recent findings support the existence of slow-growing melanomas, offering a possible explanation for anomalies in melanoma incidence reporting.